01134nas a2200397   4500000000100000000000100001008004100002653001100043653008600054653001900140653007300159653004400232653003100276653000900307653004200316653001700358653002000375653001800395653001700413100001100430700001600441700001300457700001600470700001200486700001400498700001200512700001500524700001000539700001700549700001300566245009000579250001500669300001400684490000700698020003100705       2023                            d10aHumans10a*Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/chemically induced10aCohort Studies10a*Diabetes Mellitus, Type 2/diagnosis/drug therapy/chemically induced10aAdrenal Cortex Hormones/adverse effects10a*Cerebrovascular Disorders10aCopd10achronic obstructive pulmonary disease10aCohort study10acorticosteroids10aobservational10aprimary care1 aG. Tse1 aB. Emmanuel1 aC. Ariti1 aM. Bafadhel1 aA. Papi1 aV. Carter1 aJ. Zhou1 aD. Skinner1 aX. Xu1 aH. Mullerova1 aD. Price00aA Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD  a2023/11/29  a2565-25800 v18  a1176-9106 (Print)1176-9106